Leslie McEvoy
11Patents
4h-index
24Co-inventors
60Inventor score
Filing activity: Oct 17, 1990 → Mar 11, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5196324A | Monoclonal antibodies reactive with a human atheroma associated antigen | Emerging Cross-Sectional Technologies | 28 | Expired |
| US5597726A | Monoclonal antibodies reactive with a human atheroma associated antigen | Emerging Cross-Sectional Technologies | 9 | Expired |
| US9738724B2 | Antibodies comprising site-specific non-natural amino acid residues, methods of their preparation and methods of their use | Chemistry; Metallurgy | 6 | Active |
| US10669347B2 | Antibodies comprising site-specific non-natural amino acid residues, methods of their preparation and methods of their use | Chemistry; Metallurgy | 4 | Active |
| US9732161B2 | Modified Fc proteins comprising site-specific non-natural amino acid residues, conjugates of the same, methods of their preparation and methods of their use | Chemistry; Metallurgy | 3 | Active |
| US7378509B2 | NF-kappaB oligonucleotide decoy molecules | Chemistry; Metallurgy | 3 | Expired |
| US6824781B2 | Method of impairing movement of a CLA + memeory T-cell within or to the skin of a mammal by administering a CTACK antagonist | Human Necessities | 2 | Expired |
| US10501558B2 | Modified Fc proteins comprising site-specific non-natural amino acid residues, conjugates of the same, methods of their preparation and methods of their use | Chemistry; Metallurgy | 1 | Active |
| US5719268A | Endothelial cell adhesion molecules | Human Necessities | 0 | Expired |
| US12252552B2 | Modified Fc proteins comprising site-specific non-natural amino acid residues, conjugates of the same, methods of their preparation and methods of their use | Chemistry; Metallurgy | 0 | Active |
| US11958909B2 | Antibodies comprising site-specific non-natural amino acid residues, methods of their preparation and methods of their use | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.